Lung Cancer News

Despite significantly extending survival for younger adults with advanced non-small cell lung cancer, immune checkpoint inhibitors have conferred only modest OS gains over time among patients aged older than 75 years, study results showed.

Nearly 3 years after the COVID-19 pandemic propelled telehealth from the fringes of cancer care to the mainstream, research into the use of this technology across oncology remains limited.

Drug-related pneumonitis occurred among 18% of patients receiving osimertinib for advanced epidermal growth factor receptor mutation-positive non-small cell lung cancer, according to study results published in CHEST.

In a scientific statement, the American Heart Association issued guidance on the epidemiology, diagnosis and management of cancer therapy-induced hypertension.

Patients who have been diagnosed with cancer value interventions that address their mental and emotional well-being, according to results of a survey study.

Black and Hispanic patients with cancer and caregivers appeared more likely than their white counterparts to report at least one negative care experience, according to study results.

Adults who underwent surgery for most cancer types had a significantly higher incidence of suicide compared with the U.S. general population, results of a retrospective study in JAMA Oncology showed.

Healio will present its second annual Disruptive Innovators Awards for oncology/hematology this spring.

Cancer mortality in the United States has declined by 33% since 1991, according to an American Cancer Society report released today.

In this edition, addition of tumor treating fields extends OS; atezolizumab-bevacizumab survival rates; screening leads to more stage I, less stage IV disease incidence, and more.